X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (645) 645
male (516) 516
animals (406) 406
vasoconstrictor agents - pharmacology (403) 403
female (375) 375
index medicus (311) 311
adult (268) 268
vasoconstrictor agents - administration & dosage (252) 252
vasoconstrictor agents - therapeutic use (228) 228
pharmacology & pharmacy (226) 226
middle aged (220) 220
rats (195) 195
vasoconstrictor agents - pharmacokinetics (179) 179
dose-response relationship, drug (151) 151
pharmacokinetics (137) 137
blood pressure - drug effects (135) 135
aged (124) 124
anesthesiology (123) 123
vasoconstrictor agents - adverse effects (120) 120
time factors (113) 113
double-blind method (105) 105
in vitro techniques (105) 105
migraine disorders - drug therapy (103) 103
migraine (99) 99
epinephrine (95) 95
vasoconstriction - drug effects (89) 89
treatment outcome (85) 85
adolescent (83) 83
analysis (83) 83
epinephrine - administration & dosage (83) 83
sumatriptan (82) 82
hemodynamics - drug effects (77) 77
vasoconstrictors (76) 76
vasodilator agents - pharmacology (75) 75
anesthesia (74) 74
heart rate - drug effects (74) 74
neurosciences (69) 69
rats, sprague-dawley (69) 69
anesthetics, local - administration & dosage (64) 64
clinical neurology (64) 64
medicine & public health (62) 62
rats, wistar (62) 62
cross-over studies (60) 60
norepinephrine - pharmacology (60) 60
epinephrine - pharmacology (58) 58
surgery (58) 58
norepinephrine (57) 57
hypertension (56) 56
angiotensin ii - pharmacology (55) 55
blood pressure (55) 55
double-blind (55) 55
physiology (55) 55
prospective studies (55) 55
blood-flow (54) 54
vasopressin (54) 54
drug interactions (52) 52
research (52) 52
efficacy (51) 51
muscle, smooth, vascular - drug effects (51) 51
peripheral vascular disease (51) 51
drug therapy (50) 50
lidocaine (50) 50
young adult (50) 50
care and treatment (49) 49
critical care medicine (49) 49
drugs (48) 48
pharmacology (48) 48
septic shock (47) 47
phenylephrine - pharmacology (46) 46
nitric-oxide (45) 45
swine (45) 45
anesthetics, local - pharmacokinetics (44) 44
vasoconstriction (44) 44
dosage and administration (43) 43
pediatrics (41) 41
regional blood flow - drug effects (41) 41
urology & nephrology (41) 41
infusions, intravenous (40) 40
vasoconstrictor agents - blood (40) 40
vasodilation - drug effects (40) 40
disease models, animal (39) 39
hemodynamics (39) 39
medicine, general & internal (39) 39
safety (39) 39
sumatriptan - administration & dosage (39) 39
administration, oral (38) 38
cardiac & cardiovascular systems (38) 38
injections, intravenous (38) 38
vasoconstrictor agents (38) 38
biological availability (37) 37
rat (37) 37
dogs (36) 36
health aspects (36) 36
hypotension (36) 36
clinical trials (35) 35
sumatriptan - therapeutic use (35) 35
child (34) 34
endothelium (34) 34
headache (33) 33
angiotensin ii (32) 32
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (964) 964
German (11) 11
French (3) 3
Japanese (2) 2
Norwegian (2) 2
Portuguese (2) 2
Spanish (2) 2
Bulgarian (1) 1
Dutch (1) 1
Romanian (1) 1
Russian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Controlled Release, ISSN 0168-3659, 06/2016, Volume 232, pp. 20 - 28
Low efficacy of cationic polymer-based formulations (polyplexes) for systemic gene delivery to tumors remains the crucial concern for their clinical... 
Gene delivery | Polyplexes | Nanoparticle extravasation | Tumor uptake | Tumor vasculature | VASCULAR-PERMEABILITY | MALIGNANT-MELANOMA | CHEMISTRY, MULTIDISCIPLINARY | TRANSFECTION EFFICACY | INDUCED HYPERTENSION | ENHANCED PERMEABILITY | TRANSPORT | PLASMID DNA | NITRIC-OXIDE | PHARMACOLOGY & PHARMACY | SOLID TUMOR | NONVIRAL VECTORS | Angiotensin II - administration & dosage | Vasodilator Agents - pharmacokinetics | Gene Expression Regulation, Neoplastic | Melanoma, Experimental - metabolism | Green Fluorescent Proteins - genetics | Receptor, Melanocortin, Type 1 - metabolism | Nitroglycerin - pharmacology | Drug Delivery Systems | Polyethyleneimine - pharmacokinetics | Melanoma, Experimental - physiopathology | Regional Blood Flow - drug effects | Nitroglycerin - pharmacokinetics | Nitroglycerin - administration & dosage | Female | Mice, Inbred DBA | Losartan - pharmacokinetics | Polyethylene Glycols - pharmacology | Vasoconstrictor Agents - pharmacology | Gene Transfer Techniques | Angiotensin II - pharmacology | Vasoconstrictor Agents - administration & dosage | Vasoconstrictor Agents - pharmacokinetics | Collagen Type I - metabolism | Vasodilator Agents - pharmacology | Melanoma, Experimental - therapy | Mice, Inbred C57BL | Oligopeptides - pharmacokinetics | Losartan - pharmacology | DNA - administration & dosage | Polyethylene Glycols - pharmacokinetics | Polyethyleneimine - pharmacology | Angiotensin II - pharmacokinetics | Polyethylene Glycols - administration & dosage | Polyethyleneimine - analogs & derivatives | Administration, Intravenous | Animals | Melanoma, Experimental - genetics | Polyethyleneimine - administration & dosage | Cell Line, Tumor | Luciferases, Firefly - genetics | Nanoparticles - administration & dosage | Oligopeptides - administration & dosage | Losartan - administration & dosage | Vasodilator Agents - administration & dosage | Nitrates | Drug therapy | Nitroglycerin | Tumors | Molecular genetics | Melanoma | Angiotensin | Research institutes
Journal Article
Journal Article
Journal Article
Journal Article
Journal Article
Critical Care, ISSN 1364-8535, 07/2016, Volume 20, Issue 1, p. 208
Journal Article